Klaeser Dennis L amends stock ownership filing for clarity
Klaeser Dennis L amends stock ownership filing, clarifying details on restricted stock units and common stock for Old Second Bancorp.
Main Street Capital director reports stock transactions
Main Street Capital Corp's director, John Earl Jackson, reports multiple stock transactions, emphasizing the company's commitment to shareholder value.
Lyons Updates SEC Filing on Restricted Stock Units Vesting
Billy J. Lyons Jr. amends SEC filing to clarify details on restricted stock units vesting, correcting an earlier error regarding ownership.
Hyzak Dwayne L. Reports Stock Transactions in Main Street Capital
Hyzak Dwayne L. disclosed stock transactions in Main Street Capital Corp, reflecting ongoing investment confidence in the financial sector.
Skillsoft CEO Hovsepian Reports Major Stock Transaction
Skillsoft Corp. CEO Ronald W. Hovsepian reports a significant stock transaction, reflecting ongoing leadership commitment to the company's growth.
Urquhart Nathan Acquires 39,357 Shares in Coatue Fund
Urquhart Nathan has acquired 39,357 shares in Coatue Innovative Strategies Fund, signaling strong executive commitment.
Saba Capital Management boosts stake in Ellsworth Fund
Saba Capital Management increases its stake in Ellsworth Growth & Income Fund Ltd by acquiring over 33,000 shares, signaling confidence in the fund's performance.
Geller Avi Acquires 1,600 Shares of Nova Minerals Corp
Geller Avi has purchased 1,600 shares of Nova Minerals Corp, reflecting confidence in the mining sector's future amid market fluctuations.
Magdol David L. Reports Stock Acquisitions for Main Street Capital
Magdol David L. reports stock acquisitions through a dividend reinvestment plan, signaling commitment to Main Street Capital Corp.
Sims David C increases stake in Eagle Capital Growth Fund
David C. Sims, CFO of Eagle Capital Growth Fund, boosts his stock holdings, signaling confidence in the firm's future amid industry trends.
McHugh Ryan Reports Stock Acquisitions Under DRIP Plan
McHugh Ryan's recent SEC filing details stock acquisitions under a dividend reinvestment plan, signaling growth and engagement in the financial services sector.
Ralph Alvarez Acquires Shares in Eli Lilly & Co
Ralph Alvarez, a director at Eli Lilly, reports a recent stock acquisition, emphasizing executive ownership in the pharmaceutical industry.
Griffin Jon Kevin reports stock transactions for Main Street Capital
Griffin Jon Kevin reports recent stock transactions, acquiring shares of Main Street Capital Corp, reflecting ongoing investment activity in the financial services sector.
Bruno Gabriel Acquires Shares in Lincoln Electric Holdings
Bruno Gabriel, CFO of Lincoln Electric, purchases 257 shares, emphasizing confidence in the company's future. The metalworking industry may follow suit.
Fyrwald J Erik Reports Share Acquisition in Eli Lilly & Co
Fyrwald J Erik acquires shares in Eli Lilly & Co, signaling ongoing commitment to the pharmaceutical sector. Details from SEC filing reveal transaction specifics.
Covey Michael Sean Merrill acquires shares in Franklin Covey
Covey Michael Sean Merrill has acquired 313 shares of Franklin Covey Co. as part of a long-term incentive plan, reflecting confidence in the company's future.
Main Street Capital's Solcher Acquires More Shares via DRIP
Stephen B. Solcher of Main Street Capital Corp increases his stake in the company through a dividend reinvestment plan, reflecting confidence in future performance.
Lane Brian E. reports stock transactions in Main Street Capital
Brian E. Lane reports multiple stock transactions in Main Street Capital Corp, reflecting ongoing investment through a dividend reinvestment plan.
Main Street Capital reports director stock transactions
Main Street Capital Corp discloses stock transactions by director Dunia A. Shive, reflecting ongoing investment activities and market confidence.
Harrington Robert Arthur acquires 195 shares of Cytokinetics
Harrington Robert Arthur increases his stake in Cytokinetics by acquiring 195 shares, reflecting confidence in the pharmaceutical sector.